Oregon lawmakers to vote on universal healthcare, lower drug prices

Oregon lawmakers are taking another pass at universal healthcare for the residents of state, according to a new report by The Register Guard. If SB 770 is passed, it will create a committee that would “design, implement and run a state health insurance plan.” 

Oregon is not the only state in the union to push for universal healthcare. A legislative committee in California heard proposals about how to achieve the goal of universal healthcare in the state. 

More than 35 state-level legislators are sponsors of the bill, which will allow residents who work full-time in Oregon to pay income tax, while simultaneously buying into the program. Financing of the program would come from a reserve held separately from the state’s general fund.

“This is just one step on the way to offering affordable healthcare to all Oregonians,” state Rep. Julie Fahey (D-Eugene), a chief co-sponsor of the bill, told The Register Guard.

Another high-profile bill the state legislature will vote on is SB 409—which will create a state committee to import drugs from Canada and offer them at a lower price to state pharmacies. The pharmacies will then pass those savings on to patients.

“I think that everyone believes that prescription drug prices are a huge problem,” said state Sen. Elizabeth Steiner Hayward (D-Portland).

To read the story, click the link below.

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup